Moxonidine-d 4

Overview

Moxonidine -d 4 (BDF5895-d 4 ) is the deuterium labeled Moxonidine ( HY-B0374 ). Moxonidine (BDF5895) is an orally active imidazoline type 1 receptor (I 1 -R) agonist. Moxonidine activates imidazoline I 1 receptors and α 2 adrenoceptors , affecting oxidized low-density lipoprotein uptake. Moxonidine reduces atherosclerotic lesions and lowers blood pressure. Moxonidine can be used in the study of hypertension, heart failure, and atherosclerosis.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Imidazoline Receptor | Products > Signaling Pathways > Adrenergic Receptor | Products > Signaling Pathways > LDLR

Product Information

• Catalog No.: HY-B0374S
• CAS No.: 1794811-52-1
• Molecular Formula: C9H8D4ClN5O
• Molecular Weight: 245.70
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source